Producer

Sabinsa Corporation

HQ US · East Windsor, New Jersey, USAwebsite ↗

India-founded (Dr. Muhammed Majeed), US-headquartered nutraceutical ingredient company; pioneered commercial curcumin standardization and invented BioPerine -- a patented piperine (black pepper) extract that increases curcumin bioavailability by 2000% (20-fold). This single patent reshaped the entire curcumin supplement market. Manufactures in India (Bangalore) and has US distribution from East Windsor NJ.

2

Inputs supplied

2

Goods downstream

1

Facilities

0

Stories

What they make

2 inputs Sabinsa Corporation supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Where it shows up

Goods downstream

Essential goods that depend on something Sabinsa Corporation makes, pick one to see the full supply chain.

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

  • Did you know2024

    Sabinsa takes ordinary kitchen spices and turns them into patented, clinically-positioned "nutraceutical" ingredients. Its flagship Curcumin C3 Complex is a standardized extract of turmeric — the spice in curry — sold to supplement makers as a branded, IP-protected, anti-inflammatory active; and it pairs it with BioPerine, an extract of black pepper (piperine) that's added to supplements specifically to boost the absorption of curcumin and other nutrients. So the same turmeric and pepper sitting in a spice rack become, in Sabinsa's hands, trademarked, dosage-standardized, study-backed ingredients that appear in countless supplements and functional foods. It's a clean example of how the supplement industry is built on converting cheap agricultural commodities into high-margin, branded actives through standardization and clinical positioning — the value isn't in the plant (which anyone can buy as a spice) but in the patented extraction, the consistent potency, and the studies, all controlled by a few specialist extractors.

    Sabinsa Corporation ↗
  • Incident2024

    The turmeric-to-supplement chain has a serious integrity problem that makes standardizers like Sabinsa matter — and that has drawn public-health alarm. Botanical extracts are chronically vulnerable to adulteration: curcumin supplements have been found spiked with cheaper synthetic curcumin or bulking agents, and the raw turmeric supply (overwhelmingly grown in India) has a notorious lead-contamination issue, because some processors add lead chromate, a toxic yellow pigment, to brighten turmeric's color — a documented source of lead poisoning. So a "natural" supplement or spice marketed for health can carry hidden synthetic adulterants or heavy metals, and the burden of proving purity falls on the extract makers and their testing. Sabinsa has built its brand partly on standardization, authentication and patent enforcement (it has litigated to defend its curcumin patents) precisely because the category's value depends on trust that the active is genuine, potent and clean. It's a reminder that an "all-natural" botanical supply chain can be as opaque and risk-laden as any industrial one — and that the integrity of a few extractors stands between a consumer and an adulterated or contaminated product.

    Sabinsa Corporation ↗